Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | ZTS Zoetis | ABT Abbott Laboratories |
|---|---|---|
| Price | $71.40 -2.2% | $102.61 +0.4% |
| StockIQ Score | 45D+ Moderate Risk: High | 51C- Moderate Risk: Medium |
| Technical | 13F | 19F |
| Fundamental | 70B | 72B |
| Growth | 53C- | 45D+ |
| Fair Value | 55C | 38F |
| News | 44D | 100A+ |
| Quality | 50C- | 63C+ |
| Risk | 42D | 54C- |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Zoetis outperforms Abbott Laboratories in fundamental strength, scoring 70 versus 72 isn’t a big gap, but Zoetis has a higher growth score of 53 compared to Abbott’s 45. Zoetis also has a slightly better valuation score (55 vs. 38), while Abbott leads in technicals (50 vs. 40). Both share a "MODERATE" rating, but Zoetis edges out in growth and valuation.